XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Pay vs Performance Disclosure
pure in Thousands
 12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Pay vs Performance Disclosure [Table]      
Pay vs Performance [Table Text Block]
Pay-Versus-Performance
As required by Section 952(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation actually paid and our financial performance for each of the last three completed fiscal years. In determining the “compensation actually paid” to our named executive officers (or “NEOs”), we are required to make various adjustments to amounts that have been previously reported in the Summary Compensation Table in previous years, as the SEC’s valuation methods for this disclosure differ from those required in the Summary Compensation Table. For our NEOs other than our principal executive officer (the “PEO”), compensation is reported as an average.
Year
​ ​
Summary
Compensation
Table Total
for PEO(1)
​ ​
Compensation
Actually Paid
to PEO(2)
​ ​
Average
Summary
Compensation
Table Total
for Non-PEO
NEOs(3)
​ ​
Average
Compensation
Actually Paid
to Non-PEO
NEOs(4)
​ ​
Value of Initial Fixed
$100 Investment
Based On:
​ ​
Net Income
(in thousands)(7)
​ ​
VIATRIS
Collaboration
Revenue
(in thousands)(8)
​
​
Total
Shareholder
Return(5)
​ ​
Peer Group
Total
Shareholder
Return
(^NBI)(6)
​
2022 ​ ​ ​ $ 6,272,907 ​ ​ ​ ​ $ 6,747,378 ​ ​ ​ ​ $ 971,395 ​ ​ ​ ​ $ 789,294 ​ ​ ​ ​ $ 43.34 ​ ​ ​ ​ $ 111.27 ​ ​ ​ ​ $ 872,132 ​ ​ ​ ​ $ 48,624 ​ ​
2021 ​ ​ ​ $ 4,451,942 ​ ​ ​ ​ $ 1,861,180 ​ ​ ​ ​ $ 2,841,340 ​ ​ ​ ​ $ 2,053,765 ​ ​ ​ ​ $ 42.68 ​ ​ ​ ​ $ 124.89 ​ ​ ​ ​ $ (199,426) ​ ​ ​ ​ $ 43,848 ​ ​
2020 ​ ​ ​ $ 6,577,746 ​ ​ ​ ​ $ 1,845,635 ​ ​ ​ ​ $ 2,662,221 ​ ​ ​ ​ $ 944,742 ​ ​ ​ ​ $ 68.64 ​ ​ ​ ​ $ 125.69 ​ ​ ​ ​ $ (278,017) ​ ​ ​ ​ $ 43,893 ​ ​
​
(1)
Our PEO for each year reported is Rick Winningham, our Chief Executive Officer. The dollar amounts reported in this column are the amounts of total compensation reported for Mr. Winningham in the “Total” column of the Summary Compensation Table in the applicable fiscal year.
​
(2)
In accordance with SEC rules, the following adjustments were made to determine the compensation actually paid to our PEO during fiscal years 2022, 2021 and 2020, which consisted solely of adjustments to the PEO’s equity awards:
​
Description of Adjustment
​ ​
2022
​ ​
2021
​ ​
2020
​
Summary Compensation Table – Total Compensation
​ ​ ​ $ 6,272,907 ​ ​ ​ ​ $ 4,451,942 ​ ​ ​ ​ $ 6,577,746 ​ ​
- grant date fair value of option awards and stock awards granted in the covered fiscal year
​ ​ ​ $ (4,497,647) ​ ​ ​ ​ $ (3,400,000) ​ ​ ​ ​ $ (4,977,600) ​ ​
+ fair value at fiscal year end of outstanding and unvested option awards and stock awards granted in the covered fiscal year
​ ​ ​ $ 5,173,856 ​ ​ ​ ​ $ 1,878,500 ​ ​ ​ ​ $ 3,020,900 ​ ​
+ change in fair value of outstanding and unvested option awards and stock awards granted in prior fiscal years
​ ​ ​ $ 27,094 ​ ​ ​ ​ $ (1,011,360) ​ ​ ​ ​ ($ 2,339,575) ​ ​
+ fair value on vesting date of option awards and stock awards granted in the covered fiscal year that vested during the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
+ change in fair value as of the vesting date of option
awards and stock awards granted in prior fiscal years that
vested in the covered fiscal year
​ ​ ​ $ (228,833) ​ ​ ​ ​ $ (57,903) ​ ​ ​ ​ $ (435,836) ​ ​
- fair value of as of prior fiscal year end of option awards and stock awards granted in prior fiscal years that failed to meet applicable vesting conditions during the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
+ dollar value of dividends or earnings paid on option
awards or stock awards in the covered fiscal year prior to
vesting that are not otherwise included in total
compensation
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
Total Equity Adjustments (subtotal)
​ ​ ​ $ 474,471 ​ ​ ​ ​ $ (2,590,762) ​ ​ ​ ​ $ (4,732,111) ​ ​
Compensation Actually Paid
​ ​ ​ $ 6,747,378 ​ ​ ​ ​ $ 1,861,180 ​ ​ ​ ​ $ 1,845,635 ​ ​
​
(3)
The non-PEO NEOs for each year reported are as follows:
​
For 2022: Andrew Hindman, Rhonda Farnum, Richard Graham and Ann Brady
For 2021: Andrew Hindman, Rhonda Farnum, Richard Graham, Kenneth Pitzer, Frank Pasqualone and Philip Worboys
For 2020: Andrew Hindman, Brett Haumann, Vijay Sabesan and Bradford Shafer
The dollar amounts reported in this column represent the average of the amounts reported for the non-PEO NEOs in the “Total” column of the Summary Compensation Table in the applicable fiscal year.
(4)
In accordance with SEC rules, the following adjustments were made to determine the compensation actually paid on average to our non-PEO NEOs during fiscal years 2022, 2021 and 2020, which consisted solely of adjustments to the non-PEO NEOs’ equity awards:
​
Description of Adjustment
​ ​
2022
​ ​
2021
​ ​
2020
​
Summary Compensation Table – Total Compensation
​ ​ ​ $ 971,395 ​ ​ ​ ​ $ 2,841,340 ​ ​ ​ ​ $ 2,662,221 ​ ​
- grant date fair value of option awards and stock awards granted in the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ $ (2,316,098) ​ ​ ​ ​ $ (1,746,186) ​ ​
+ fair value at fiscal year end of outstanding and unvested option awards and stock awards granted in the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ $ 2,069,643 ​ ​ ​ ​ $ 1,059,758 ​ ​
+ change in fair value of outstanding and unvested option awards and stock awards granted in prior fiscal years
​ ​ ​ $ 86,152 ​ ​ ​ ​ $ (463,459) ​ ​ ​ ​ $ (867,244) ​ ​
+ fair value on vesting date of option awards and stock
awards granted in the covered fiscal year that vested during
the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ $ 34,125 ​ ​ ​ ​ ​ — ​ ​
+ change in fair value as of the vesting date of option awards
and stock awards granted in prior fiscal years that vested in
the covered fiscal year
​ ​ ​ $ (151,278) ​ ​ ​ ​ $ (94,489) ​ ​ ​ ​ $ (163,807) ​ ​
- fair value of as of prior fiscal year end of option awards and
stock awards granted in prior fiscal years that failed to
meet applicable vesting conditions during the covered fiscal
year
​ ​ ​ $ (116,975) ​ ​ ​ ​ $ (17,296) ​ ​ ​ ​ ​ — ​ ​
+ dollar value of dividends or earnings paid on option awards
or stock awards in the covered fiscal year prior to vesting
that are not otherwise included in total compensation
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
Total Equity Adjustments (subtotal)
​ ​ ​ $ (182,101) ​ ​ ​ ​ $ (787,575) ​ ​ ​ ​ $ (1,717,479) ​ ​
Compensation Actually Paid
​ ​ ​ $ 789,294 ​ ​ ​ ​ $ 2,053,765 ​ ​ ​ ​ $ 944,742 ​ ​
​
(5)
Cumulative total shareholder return on our ordinary shares from December 31, 2019 through December 31, 2020, December 31, 2021, and December 31, 2022 respectively. Assumes the investment of $100 on December 31, 2019 in our ordinary shares and assumes the reinvestment of dividends, if any, although dividends have never been declared on our ordinary shares.
​
(6)
Cumulative total shareholder return on the NASDAQ Biotechnology Index from December 31, 2019 through December 31, 2020, December 31, 2021, and December 31, 2022 respectively. Assumes the investment of $100 on December 31, 2019 in the NASDAQ Biotechnology Index and assumes the reinvestment of dividends.
​
(7)
The dollar amounts reported represent the amount of net income reflected in our audited financial statements for the applicable year.
​
(8)
The dollar amounts reported represent the amount of Viatris Collaboration Revenue reflected in our audited financial statements for the applicable year.
   
Company Selected Measure Name VIATRIS Collaboration Revenue    
Named Executive Officers, Footnote [Text Block]
(1)
Our PEO for each year reported is Rick Winningham, our Chief Executive Officer. The dollar amounts reported in this column are the amounts of total compensation reported for Mr. Winningham in the “Total” column of the Summary Compensation Table in the applicable fiscal year.
​
(2)
In accordance with SEC rules, the following adjustments were made to determine the compensation actually paid to our PEO during fiscal years 2022, 2021 and 2020, which consisted solely of adjustments to the PEO’s equity awards:
​
Description of Adjustment
​ ​
2022
​ ​
2021
​ ​
2020
​
Summary Compensation Table – Total Compensation
​ ​ ​ $ 6,272,907 ​ ​ ​ ​ $ 4,451,942 ​ ​ ​ ​ $ 6,577,746 ​ ​
- grant date fair value of option awards and stock awards granted in the covered fiscal year
​ ​ ​ $ (4,497,647) ​ ​ ​ ​ $ (3,400,000) ​ ​ ​ ​ $ (4,977,600) ​ ​
+ fair value at fiscal year end of outstanding and unvested option awards and stock awards granted in the covered fiscal year
​ ​ ​ $ 5,173,856 ​ ​ ​ ​ $ 1,878,500 ​ ​ ​ ​ $ 3,020,900 ​ ​
+ change in fair value of outstanding and unvested option awards and stock awards granted in prior fiscal years
​ ​ ​ $ 27,094 ​ ​ ​ ​ $ (1,011,360) ​ ​ ​ ​ ($ 2,339,575) ​ ​
+ fair value on vesting date of option awards and stock awards granted in the covered fiscal year that vested during the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
+ change in fair value as of the vesting date of option
awards and stock awards granted in prior fiscal years that
vested in the covered fiscal year
​ ​ ​ $ (228,833) ​ ​ ​ ​ $ (57,903) ​ ​ ​ ​ $ (435,836) ​ ​
- fair value of as of prior fiscal year end of option awards and stock awards granted in prior fiscal years that failed to meet applicable vesting conditions during the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
+ dollar value of dividends or earnings paid on option
awards or stock awards in the covered fiscal year prior to
vesting that are not otherwise included in total
compensation
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
Total Equity Adjustments (subtotal)
​ ​ ​ $ 474,471 ​ ​ ​ ​ $ (2,590,762) ​ ​ ​ ​ $ (4,732,111) ​ ​
Compensation Actually Paid
​ ​ ​ $ 6,747,378 ​ ​ ​ ​ $ 1,861,180 ​ ​ ​ ​ $ 1,845,635 ​ ​
​
(3)
The non-PEO NEOs for each year reported are as follows:
​
For 2022: Andrew Hindman, Rhonda Farnum, Richard Graham and Ann Brady
For 2021: Andrew Hindman, Rhonda Farnum, Richard Graham, Kenneth Pitzer, Frank Pasqualone and Philip Worboys
For 2020: Andrew Hindman, Brett Haumann, Vijay Sabesan and Bradford Shafer
The dollar amounts reported in this column represent the average of the amounts reported for the non-PEO NEOs in the “Total” column of the Summary Compensation Table in the applicable fiscal year.
(4)
In accordance with SEC rules, the following adjustments were made to determine the compensation actually paid on average to our non-PEO NEOs during fiscal years 2022, 2021 and 2020, which consisted solely of adjustments to the non-PEO NEOs’ equity awards:
​
Description of Adjustment
​ ​
2022
​ ​
2021
​ ​
2020
​
Summary Compensation Table – Total Compensation
​ ​ ​ $ 971,395 ​ ​ ​ ​ $ 2,841,340 ​ ​ ​ ​ $ 2,662,221 ​ ​
- grant date fair value of option awards and stock awards granted in the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ $ (2,316,098) ​ ​ ​ ​ $ (1,746,186) ​ ​
+ fair value at fiscal year end of outstanding and unvested option awards and stock awards granted in the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ $ 2,069,643 ​ ​ ​ ​ $ 1,059,758 ​ ​
+ change in fair value of outstanding and unvested option awards and stock awards granted in prior fiscal years
​ ​ ​ $ 86,152 ​ ​ ​ ​ $ (463,459) ​ ​ ​ ​ $ (867,244) ​ ​
+ fair value on vesting date of option awards and stock
awards granted in the covered fiscal year that vested during
the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ $ 34,125 ​ ​ ​ ​ ​ — ​ ​
+ change in fair value as of the vesting date of option awards
and stock awards granted in prior fiscal years that vested in
the covered fiscal year
​ ​ ​ $ (151,278) ​ ​ ​ ​ $ (94,489) ​ ​ ​ ​ $ (163,807) ​ ​
- fair value of as of prior fiscal year end of option awards and
stock awards granted in prior fiscal years that failed to
meet applicable vesting conditions during the covered fiscal
year
​ ​ ​ $ (116,975) ​ ​ ​ ​ $ (17,296) ​ ​ ​ ​ ​ — ​ ​
+ dollar value of dividends or earnings paid on option awards
or stock awards in the covered fiscal year prior to vesting
that are not otherwise included in total compensation
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
Total Equity Adjustments (subtotal)
​ ​ ​ $ (182,101) ​ ​ ​ ​ $ (787,575) ​ ​ ​ ​ $ (1,717,479) ​ ​
Compensation Actually Paid
​ ​ ​ $ 789,294 ​ ​ ​ ​ $ 2,053,765 ​ ​ ​ ​ $ 944,742 ​ ​
   
Peer Group Issuers, Footnote [Text Block]
(6)
Cumulative total shareholder return on the NASDAQ Biotechnology Index from December 31, 2019 through December 31, 2020, December 31, 2021, and December 31, 2022 respectively. Assumes the investment of $100 on December 31, 2019 in the NASDAQ Biotechnology Index and assumes the reinvestment of dividends.
   
PEO Total Compensation Amount $ 6,272,907 $ 4,451,942 $ 6,577,746
PEO Actually Paid Compensation Amount $ 6,747,378 1,861,180 1,845,635
Adjustment To PEO Compensation, Footnote [Text Block]
(2)
In accordance with SEC rules, the following adjustments were made to determine the compensation actually paid to our PEO during fiscal years 2022, 2021 and 2020, which consisted solely of adjustments to the PEO’s equity awards:
​
Description of Adjustment
​ ​
2022
​ ​
2021
​ ​
2020
​
Summary Compensation Table – Total Compensation
​ ​ ​ $ 6,272,907 ​ ​ ​ ​ $ 4,451,942 ​ ​ ​ ​ $ 6,577,746 ​ ​
- grant date fair value of option awards and stock awards granted in the covered fiscal year
​ ​ ​ $ (4,497,647) ​ ​ ​ ​ $ (3,400,000) ​ ​ ​ ​ $ (4,977,600) ​ ​
+ fair value at fiscal year end of outstanding and unvested option awards and stock awards granted in the covered fiscal year
​ ​ ​ $ 5,173,856 ​ ​ ​ ​ $ 1,878,500 ​ ​ ​ ​ $ 3,020,900 ​ ​
+ change in fair value of outstanding and unvested option awards and stock awards granted in prior fiscal years
​ ​ ​ $ 27,094 ​ ​ ​ ​ $ (1,011,360) ​ ​ ​ ​ ($ 2,339,575) ​ ​
+ fair value on vesting date of option awards and stock awards granted in the covered fiscal year that vested during the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
+ change in fair value as of the vesting date of option
awards and stock awards granted in prior fiscal years that
vested in the covered fiscal year
​ ​ ​ $ (228,833) ​ ​ ​ ​ $ (57,903) ​ ​ ​ ​ $ (435,836) ​ ​
- fair value of as of prior fiscal year end of option awards and stock awards granted in prior fiscal years that failed to meet applicable vesting conditions during the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
+ dollar value of dividends or earnings paid on option
awards or stock awards in the covered fiscal year prior to
vesting that are not otherwise included in total
compensation
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
Total Equity Adjustments (subtotal)
​ ​ ​ $ 474,471 ​ ​ ​ ​ $ (2,590,762) ​ ​ ​ ​ $ (4,732,111) ​ ​
Compensation Actually Paid
​ ​ ​ $ 6,747,378 ​ ​ ​ ​ $ 1,861,180 ​ ​ ​ ​ $ 1,845,635 ​ ​
   
Non-PEO NEO Average Total Compensation Amount $ 971,395 2,841,340 2,662,221
Non-PEO NEO Average Compensation Actually Paid Amount $ 789,294 2,053,765 944,742
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
(4)
In accordance with SEC rules, the following adjustments were made to determine the compensation actually paid on average to our non-PEO NEOs during fiscal years 2022, 2021 and 2020, which consisted solely of adjustments to the non-PEO NEOs’ equity awards:
​
Description of Adjustment
​ ​
2022
​ ​
2021
​ ​
2020
​
Summary Compensation Table – Total Compensation
​ ​ ​ $ 971,395 ​ ​ ​ ​ $ 2,841,340 ​ ​ ​ ​ $ 2,662,221 ​ ​
- grant date fair value of option awards and stock awards granted in the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ $ (2,316,098) ​ ​ ​ ​ $ (1,746,186) ​ ​
+ fair value at fiscal year end of outstanding and unvested option awards and stock awards granted in the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ $ 2,069,643 ​ ​ ​ ​ $ 1,059,758 ​ ​
+ change in fair value of outstanding and unvested option awards and stock awards granted in prior fiscal years
​ ​ ​ $ 86,152 ​ ​ ​ ​ $ (463,459) ​ ​ ​ ​ $ (867,244) ​ ​
+ fair value on vesting date of option awards and stock
awards granted in the covered fiscal year that vested during
the covered fiscal year
​ ​ ​ ​ — ​ ​ ​ ​ $ 34,125 ​ ​ ​ ​ ​ — ​ ​
+ change in fair value as of the vesting date of option awards
and stock awards granted in prior fiscal years that vested in
the covered fiscal year
​ ​ ​ $ (151,278) ​ ​ ​ ​ $ (94,489) ​ ​ ​ ​ $ (163,807) ​ ​
- fair value of as of prior fiscal year end of option awards and
stock awards granted in prior fiscal years that failed to
meet applicable vesting conditions during the covered fiscal
year
​ ​ ​ $ (116,975) ​ ​ ​ ​ $ (17,296) ​ ​ ​ ​ ​ — ​ ​
+ dollar value of dividends or earnings paid on option awards
or stock awards in the covered fiscal year prior to vesting
that are not otherwise included in total compensation
​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​
Total Equity Adjustments (subtotal)
​ ​ ​ $ (182,101) ​ ​ ​ ​ $ (787,575) ​ ​ ​ ​ $ (1,717,479) ​ ​
Compensation Actually Paid
​ ​ ​ $ 789,294 ​ ​ ​ ​ $ 2,053,765 ​ ​ ​ ​ $ 944,742 ​ ​
   
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Compensation Actually Paid and Total Shareholder Return
The following graph reflects the relationship between the PEO and average non-PEO NEO “compensation actually paid” ​(“CAP”), total compensation from the Summary Compensation Table
(“SCT”), our cumulative Total Shareholder Return (“TSR”) and the TSR of the NASDAQ Biotechnology Index, assuming an initial fixed investment on December 31, 2019 of $100, for the fiscal years ended December 31, 2022, 2021 and 2020. In addition, the SCT total compensation of our PEO and the average SCT total compensation for our non-PEO NEOs, each as disclosed in the table above, are included in the following graph as supplemental disclosures for each of the periods presented.
[MISSING IMAGE: bc_theravance-4c.jpg]
A significant portion of our NEOs’ compensation consists of equity awards. As a result, the change between the values disclosed in our Summary Compensation Table and Compensation Actually Paid tends to be directionally aligned with changes in our TSR.
   
Compensation Actually Paid vs. Net Income [Text Block]
Compensation Actually Paid and Net Income
The following graph reflects the relationship between the PEO and average non-PEO NEO CAP, total compensation from the SCT and our net income (loss) for the fiscal years ended December 31, 2022, 2021 and 2020. While we are required by SEC rules to disclose the relationship between our net income and “compensation actually paid” to our NEOs, this is not a metric our compensation committee currently uses in evaluating our NEOs’ compensation. In addition, the SCT total compensation of our PEO and the average SCT total compensation for our non-PEO NEOs, each as disclosed in the table above, are included in the following graph as supplemental disclosures for each of the periods presented.
[MISSING IMAGE: bc_netincome-4c.jpg]
   
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Compensation Actually Paid and VIATRIS Collaboration Revenue
The following graph reflects the relationship between the PEO and average non-PEO NEO CAP, total compensation from the SCT and our VIATRIS Collaboration Revenue for the fiscal years ended December 31, 2022, 2021 and 2020. In addition, the SCT total compensation of our PEO and the average SCT total compensation for our non-PEO NEOs, each as disclosed in the table above, are included in the following graph as supplemental disclosures for each of the periods presented.
[MISSING IMAGE: bc_collaboration-4c.jpg]
   
Tabular List [Table Text Block]
Most Important Performance Measures
Every year our board of directors sets a list of corporate goals as part of our annual business plan. These goals are used, among others, to evaluate our performance and the performance of our executive
officers and are used in our executive compensation programs, in particular in our annual bonus program. For the full list of 2022 corporate goals, please see “Compensation Discussion and Analysis — Annual Cash Incentive Compensation” above.
For 2022, the most important performance measures used to inform our executive compensation decisions included the following:
​
•
VIATRIS Collaboration Revenue, which incorporates YUPELRI® (Revefenacin) Inhalation Solution net sales performance
​
•
Clinical study preparation (regulatory meetings), commencement, enrollment and results
​
•
Research program advancement (development candidate and indication nomination)
​
•
Corporate and business development achievements
​
•
Financial achievements, including cash flow positivity or non-GAAP profitability
​
•
Employee resources and cultural strength
   
Total Shareholder Return Amount $ 43.34 42.68 68.64
Peer Group Total Shareholder Return Amount 111.27 124.89 125.69
Net Income (Loss) $ 872,132,000 $ (199,426,000) $ (278,017,000)
Company Selected Measure Amount 48,624 43,848 43,893
PEO Name Rick Winningham Rick Winningham Rick Winningham
Additional 402(v) Disclosure [Text Block]
(5)
Cumulative total shareholder return on our ordinary shares from December 31, 2019 through December 31, 2020, December 31, 2021, and December 31, 2022 respectively. Assumes the investment of $100 on December 31, 2019 in our ordinary shares and assumes the reinvestment of dividends, if any, although dividends have never been declared on our ordinary shares.
   
Measure [Axis]: 1      
Pay vs Performance Disclosure [Table]      
Measure Name VIATRIS Collaboration Revenue    
Non-GAAP Measure Description [Text Block]
(8)
The dollar amounts reported represent the amount of Viatris Collaboration Revenue reflected in our audited financial statements for the applicable year.
   
Measure [Axis]: 2      
Pay vs Performance Disclosure [Table]      
Measure Name Clinical study preparation (regulatory meetings), commencement, enrollment and results    
Measure [Axis]: 3      
Pay vs Performance Disclosure [Table]      
Measure Name Research program advancement (development candidate and indication nomination)    
Measure [Axis]: 4      
Pay vs Performance Disclosure [Table]      
Measure Name Corporate and business development achievements    
Measure [Axis]: 5      
Pay vs Performance Disclosure [Table]      
Measure Name Financial achievements, including cash flow positivity or non-GAAP profitability    
Measure [Axis]: 6      
Pay vs Performance Disclosure [Table]      
Measure Name Employee resources and cultural strength    
Total Net Adjustments For Equity Awards [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ 474,471 $ (2,590,762) $ (4,732,111)
Total Equity Awards Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (4,497,647) (3,400,000) (4,977,600)
Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 5,173,856 1,878,500 3,020,900
Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 27,094 (1,011,360) (2,339,575)
Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (228,833) (57,903) (435,836)
Non-PEO NEO [Member] | Total Net Adjustments For Equity Awards [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (182,101) (787,575) (1,717,479)
Non-PEO NEO [Member] | Total Equity Awards Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount   (2,316,098) (1,746,186)
Non-PEO NEO [Member] | Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount   2,069,643 1,059,758
Non-PEO NEO [Member] | Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 86,152 (463,459) (867,244)
Non-PEO NEO [Member] | Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (151,278) (94,489) $ (163,807)
Non-PEO NEO [Member] | Change In Fair Value As Of Vesting Date Of Current Year Awards Vested During Current Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount   34,125  
Non-PEO NEO [Member] | Adjustments For Equity Awards Failed To Meet Performance Conditions [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ (116,975) $ (17,296)